1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Colopavine Hydrochloride Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 100 mg/tablet
  • 1.3.3 200 mg/tablet
• 1.4 Market Analysis by Dosage Form
  • 1.4.1 Overview: Global Colopavine Hydrochloride Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
  • 1.4.2 Tablet
  • 1.4.3 Capsule
• 1.5 Market Analysis by Application
  • 1.5.1 Overview: Global Colopavine Hydrochloride Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.5.2 Chronic Bepatitis B, CHB
  • 1.5.3 Antiviral Agent
  • 1.5.4 Others
• 1.6 Global Colopavine Hydrochloride Market Size & Forecast
  • 1.6.1 Global Colopavine Hydrochloride Consumption Value (2021 & 2025 & 2032)
  • 1.6.2 Global Colopavine Hydrochloride Sales Quantity (2021-2032)
  • 1.6.3 Global Colopavine Hydrochloride Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Beijing Kawin Technology
  • 2.1.1 Beijing Kawin Technology Details
  • 2.1.2 Beijing Kawin Technology Major Business
  • 2.1.3 Beijing Kawin Technology Colopavine Hydrochloride Product and Services
  • 2.1.4 Beijing Kawin Technology Colopavine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Beijing Kawin Technology Recent Developments/Updates

3 Competitive Environment: Colopavine Hydrochloride by Manufacturer

• 3.1 Global Colopavine Hydrochloride Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Colopavine Hydrochloride Revenue by Manufacturer (2021-2026)
• 3.3 Global Colopavine Hydrochloride Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Colopavine Hydrochloride by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Colopavine Hydrochloride Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Colopavine Hydrochloride Manufacturer Market Share in 2025
• 3.5 Colopavine Hydrochloride Market: Overall Company Footprint Analysis
  • 3.5.1 Colopavine Hydrochloride Market: Region Footprint
  • 3.5.2 Colopavine Hydrochloride Market: Company Product Type Footprint
  • 3.5.3 Colopavine Hydrochloride Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Colopavine Hydrochloride Market Size by Region
  • 4.1.1 Global Colopavine Hydrochloride Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Colopavine Hydrochloride Consumption Value by Region (2021-2032)
  • 4.1.3 Global Colopavine Hydrochloride Average Price by Region (2021-2032)
• 4.2 North America Colopavine Hydrochloride Consumption Value (2021-2032)
• 4.3 Europe Colopavine Hydrochloride Consumption Value (2021-2032)
• 4.4 Asia-Pacific Colopavine Hydrochloride Consumption Value (2021-2032)
• 4.5 South America Colopavine Hydrochloride Consumption Value (2021-2032)
• 4.6 Middle East & Africa Colopavine Hydrochloride Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Colopavine Hydrochloride Sales Quantity by Type (2021-2032)
• 5.2 Global Colopavine Hydrochloride Consumption Value by Type (2021-2032)
• 5.3 Global Colopavine Hydrochloride Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Colopavine Hydrochloride Sales Quantity by Application (2021-2032)
• 6.2 Global Colopavine Hydrochloride Consumption Value by Application (2021-2032)
• 6.3 Global Colopavine Hydrochloride Average Price by Application (2021-2032)

7 North America

• 7.1 North America Colopavine Hydrochloride Sales Quantity by Type (2021-2032)
• 7.2 North America Colopavine Hydrochloride Sales Quantity by Application (2021-2032)
• 7.3 North America Colopavine Hydrochloride Market Size by Country
  • 7.3.1 North America Colopavine Hydrochloride Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Colopavine Hydrochloride Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Colopavine Hydrochloride Sales Quantity by Type (2021-2032)
• 8.2 Europe Colopavine Hydrochloride Sales Quantity by Application (2021-2032)
• 8.3 Europe Colopavine Hydrochloride Market Size by Country
  • 8.3.1 Europe Colopavine Hydrochloride Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Colopavine Hydrochloride Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Colopavine Hydrochloride Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Colopavine Hydrochloride Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Colopavine Hydrochloride Market Size by Region
  • 9.3.1 Asia-Pacific Colopavine Hydrochloride Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Colopavine Hydrochloride Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Colopavine Hydrochloride Sales Quantity by Type (2021-2032)
• 10.2 South America Colopavine Hydrochloride Sales Quantity by Application (2021-2032)
• 10.3 South America Colopavine Hydrochloride Market Size by Country
  • 10.3.1 South America Colopavine Hydrochloride Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Colopavine Hydrochloride Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Colopavine Hydrochloride Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Colopavine Hydrochloride Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Colopavine Hydrochloride Market Size by Country
  • 11.3.1 Middle East & Africa Colopavine Hydrochloride Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Colopavine Hydrochloride Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Colopavine Hydrochloride Market Drivers
• 12.2 Colopavine Hydrochloride Market Restraints
• 12.3 Colopavine Hydrochloride Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Colopavine Hydrochloride and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Colopavine Hydrochloride
• 13.3 Colopavine Hydrochloride Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Colopavine Hydrochloride Typical Distributors
• 14.3 Colopavine Hydrochloride Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Colopavine Hydrochloride market size was valued at US$ 196 million in 2025 and is forecast to a readjusted size of US$ 469 million by 2032 with a CAGR of 9.8% during review period.
In 2025, global Coblopasvir Hydrochloride production reached approximately 520,000 units.Coblopasvir Hydrochloride is a Class 1.1 innovative small-molecule anti-hepatitis C virus (HCV) drug independently developed in China. It belongs to the category of direct-acting antivirals (DAA) and represents a new-generation oral NS5A inhibitor. Originally researched and developed by domestic pharmaceutical enterprises with full independent intellectual property rights, it fills the gap of high-cure-rate domestic drugs for hepatitis C treatment. Included in the national medical insurance catalogue, it serves as a core drug for the standardized treatment of chronic hepatitis C.
Coblopasvir Hydrochloride is an NS5A inhibitor targeting hepatitis C virus (HCV), typically used in combination with other direct-acting antivirals (DAAs), and demonstrates a certain level of competitiveness in China’s antiviral treatment market. With the strengthening of HCV screening efforts and the advancement of the public health goal of “eliminating hepatitis C,” diagnosis and treatment rates continue to improve, providing a stable clinical demand for this drug. From a market landscape perspective, DAA combination regimens centered on Sofosbuvir, along with imported originator drugs, still dominate the market. However, coblopasvir hydrochloride, leveraging its domestic R&D advantages, price competitiveness, and flexibility in combination regimens, is well positioned to gain market share in primary healthcare settings and among price-sensitive patient populations. On the policy side, national reimbursement negotiations and volume-based procurement continue to put downward pressure on drug prices, while significantly improving patient accessibility and accelerating market uptake. From a competitive standpoint, the emergence of various NS5A inhibitors and pan-genotypic DAA regimens from both domestic and international players is intensifying market competition. Therefore, the future market performance of coblopasvir hydrochloride will depend on its clinical positioning within combination therapies, the accumulation of real-world efficacy and safety data, as well as its overall competitiveness in pricing, distribution channels, and insurance coverage.
This report is a detailed and comprehensive analysis for global Colopavine Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Colopavine Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Colopavine Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Colopavine Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Colopavine Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colopavine Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colopavine Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Beijing Kawin Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Colopavine Hydrochloride market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100 mg/tablet
200 mg/tablet
Market segment by Dosage Form
Tablet
Capsule
Market segment by Application
Chronic Bepatitis B, CHB
Antiviral Agent
Others
Major players covered
Beijing Kawin Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Colopavine Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Colopavine Hydrochloride, with price, sales quantity, revenue, and global market share of Colopavine Hydrochloride from 2021 to 2026.
Chapter 3, the Colopavine Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Colopavine Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Colopavine Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Colopavine Hydrochloride.
Chapter 14 and 15, to describe Colopavine Hydrochloride sales channel, distributors, customers, research findings and conclusion.